Summary:
Johns Hopkins CIR is seeking healthy volunteers age 18-55 for an outpatient study investigating a new intravenous (IV) drug called AV-1. This drug is being tested to see if it will treat or prevent dengue infection.
Qualified Participants Must:
• 5 months length of study
•
at least 2 screening visits to determine eligibility
•
one IV infusion visit where participants receive study drug or placebo (IV infusion takes one hour, study visit will take 6-8 hours)
•
one dengue virus challenge visit
•
15 follow-up appointments
Qualified Participants May Receive:
Up to $3,425 for your time and participation if enrolled